Unveiling FOS as a Potential Diagnostic Biomarker and Emetine as a Prospective Therapeutic Agent for Diabetic Nephropathy.
Jiaqiong LinXiaoyong LiYan LinZena HuangFei HeFu XiongPublished in: Journal of inflammation research (2023)
as a promising diagnostic biomarker and emetine as a potential therapeutic candidate for DN. These findings enhance our understanding of DN pathogenesis and present novel prospects for therapeutic strategies.